Unknown

Dataset Information

Current research toward optimizing dosing of first-line antituberculosis treatment.


ABSTRACT:

Introduction

Drug concentrations in tuberculosis patients on standard regimens vary widely with clinically important consequences. Areas covered: We review the available literature identifying factors correlated with pharmacokinetic variability of antituberculosis drugs. Based on population pharmacokinetic models and the weight, height, and sex distributions in a large data base of African tuberculosis patients, we propose simplified weight-based doses of the available fixed dose combination(FDC) for adults with drug susceptible tuberculosis. Emerging studies will support optimized weight-based dosing for children. Other sources of important pharmacokinetic variability include genetic variants, drug-drug interactions, formulation quality, and methods of preparation and administrati

SUBMITTER: McIlleron H 

PROVIDER: S-EPMC6364307 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature